CCO Treatment Updates

Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection

Latest Insights Into Cardiovascular Risk in HIV-Infected Patients

Module 1 of 2

Faculty:
Jens D. Lundgren, MD, DMSc Signe Westring Worm, MD

CME CREDIT INFORMATION

Release Date: 11/20/07

Expiration Date: 11/19/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status

Jens D. Lundgren, MD, DMSc, and Signe Westring Worm, MD, review elements of cardiovascular risk including those unique to the HIV-infected population.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe how the epidemiology of cardiovascular risk is different in the HIV-infected population when compared with the general population
Discuss the contribution of traditional risk factors to cardiovascular risk in HIV-infected patients
Explain how untreated HIV contributes to cardiovascular risk in HIV-infected patients
Relate how antiretroviral therapy contributes to cardiovascular risk in HIV-infected patients
List several actions physicians may take to monitor and to mitigate cardiovascular risk in HIV-infected patients

Antiretroviral Strategies for Minimizing Cardiovascular Risk

Module 2 of 2

Faculty:
Sally Hodder, MD

CME CREDIT INFORMATION

Release Date: 12/12/07

Expiration Date: 12/11/08

Physicians: maximum of 2.5 AMA PRA Category 1 Credit(s)™

Pharmacists: 2.5 contact hours (0.25 CEUs)

Registered Nurses: 2.5 Nursing CE credits

Status: Please log in to view status

Sally Hodder, MD, discusses antiretroviral strategies that may be used to manage cardiovascular risk in HIV-infected individuals.

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the guidelines on cardiovascular risk management in HIV settings
Explain the benefits and limitations of lipid-lowering therapy in HIV-infected patients
Discuss data concerning the selection of antiretrovirals to minimize cardiovascular risk
Identify antiretroviral therapy modification strategies to reduce cardiovascular risk

Interactive Case Challenges

Selection of an Initial Regimen for a Patient With a Family History of Cardiovascular Disease

Faculty:
William G. Powderly, MD

CME CREDIT INFORMATION

Release Date: 11/20/07

Expiration Date: 11/19/08

Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

William G. Powderly, MD, challenges your knowledge of assessing cardiovascular risk for this patient as you select his initial regimen.

Learning Objectives

Upon completion of this activity, participants should be able to:

List parameters that are important in assessment of cardiovascular risk in HIV-infected patients
Describe the role of modifying traditional risk factors in management of cardiovascular risk in HIV-infected patients
Discuss the role of antiretroviral selection as part of a strategy of lipid management for HIV-infected patients

Management of Dyslipidemia in an HIV-Infected Man With Grave Cardiac Risk

Faculty:
Jens D. Lundgren, MD, DMSc Signe Westring Worm, MD

CME CREDIT INFORMATION

Release Date: 11/20/07

Expiration Date: 11/19/08

Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Jens D. Lundgren, MD, DMSc, and Signe W. Worm, MD, guide participants through the assessment of cardiac risk and treatment choices in a middle-aged patient with a high risk of a cardiovascular event.

Learning Objectives

Upon completion of this activity, participants should be able to:

Name the factors that are included in the assessment of 10-year cardiovascular risk by the Framingham calculation
Discuss guideline recommendations for treatment of dyslipidemia in HIV-infected patients
Describe the role of statins in the treatment of dyslipidemia in HIV-infected patients
Explain how modification of antiretroviral therapy contributes to the management of dyslipidemia in HIV-infected patients

Slideset Module

Update on Cardiovascular Risk and Antiretroviral Therapy

Faculty:
Andrew Carr, MBBS, MD, FRACP, FRCP

CME CREDIT INFORMATION

Release Date: 12/14/07

Expiration Date: 12/13/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Andrew Carr, MD, reviews current data that have advanced our knowledge of cardiovascular risk in HIV-infected patients.

Learning Objectives

Upon completion of this activity, participants should be able to:

Review current data on cardiovascular risk factors in HIV-infected patients
Describe the recommendations for clinical management of lipids in HIV-infected patients
Discuss the role of antiretroviral selection and modification as part of a strategy of lipid management for HIV-infected patients

Downloadable Slides: Update on Cardiovascular Risk and Antiretroviral Therapy

Andrew Carr, MD, reviews current data that have advanced our knowledge of cardiovascular risk in HIV-infected patients.

Format: Microsoft PowerPoint (.ppt) | File size: 1,575 KB

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.